SUNP

Sun Pharmaceutical Industries Limited

SUNPHARMA.NSE sunpharma.com + Research + Basket
ISIN INE044A01036
Employees 47,000
Phone 91 22 4324 4324
Fiscal year end March
Address Sun House, Mumbai, India, 400063
1,761.00
+3.50 (+0.20%)
INR · NSE
52-week range
1,569.37
2,046.90
Trading at 40% of the 52-week range
Market Cap
4.22T
P/E Ratio
34.52
Forward P/E
28.25
Book Value
348.31
Div. Yield
0.00%
% Institutions
29.58%
% Insiders
55.61%

1 Year

+3.6%

3 Year

+62.3%

10 Year

+161.6%
Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Actions

Add an action for SUNPHARMA.NSE, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Dilip Shantilal Shanghvi Executive Chairman of the Board 1955
Mr. Kirti Wardhaman Ganorkar Managing Director 1967
Mr. Aalok Dilip Shanghvi COO, Head of Global Generics R&D, Business Devp., and Whole Time Director 1984
Ms. Vidhi Dilip Shanghvi Whole-time Director 1987
Ms. Jayashree Satagopan Executive VP & CFO 1968
Mr. Dheeraj Prasad Sinha BE EVP & Chief Information Officer 1971
Dr. Abhishek Sharma VP, Head of Investor Relations & Strategic Projects NA
Mr. Anoop Deshpande Company Secretary & Compliance Officer NA
Mr. Kalyanasundaram Subramanian Director of Corporate Development 1954
Ms. Sana Shaikh Head of Marketing NA

Financial Highlights

▼
Market Cap: $4,216.83B
EBITDA: $165.83B
P/E Ratio: $34.52
PEG Ratio: $1.04
Book Value: $348.31
Dividend/Share: $0.00
Dividend Yield: 0.00%
Earnings/Share: $50.91
Profit Margin: 20.19%
Operating Margin: 23.25%
ROA (TTM): 8.47%
ROE (TTM): 14.72%
Revenue (TTM): $599.11B
Revenue/Share (TTM): $249.86
Earnings Growth (YOY): 27.40%
Revenue Growth (YOY): 10.50%

Valuation Metrics

Enterprise Value: $3,910.17B
Trailing P/E: 34.52
Forward P/E: 28.25

Shares Statistics

Shares Outstanding: 2.40B
Shares Float: 1.06B
% Insiders: 55.61%
% Institutions: 29.58%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$584.62B
Cost of Goods Sold
adjust
$-259.00B
Gross Profit
subtotal
$325.62B
SG&A
adjust
$-114.77B
R&D
adjust
$-34.74B
Other Operating Expense
adjust
$-40.57B
Operating Income
subtotal
$135.53B
Other / Non-Operating Items
adjust
$-20.74B
Net Income
subtotal
$114.79B

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about SUNPHARMA.NSE!